EPO Patents = 2

Forward Citations = 38

Loading Chart...

12 inventors (with patents filed for the assignee):

Harald Schmidt (2 out of 5 patents)

Frank Tegtmeier (1 out of 12 patents)

Robert Doblhofer (1 out of 4 patents)

4. Wolfgang Pfleiderer (1 out of 32 patents)

5. Ulrich Walter (1 out of 4 patents)

6. Lothar Fröhlich (1 out of 5 patents)

7. Ulrike Zabel (1 out of 1 patent)

8. Wolfgang Poller (1 out of 1 patent)

9. Peter Kotsonis (1 out of 1 patent)

10. Shahriyar Taghavi-Moghadam (1 out of 1 patent)

11. Martin Eigenthaler (1 out of 1 patent)

12. Heinz Hoschuetzky (1 out of 1 patent)

13. Peter Drückes (1 patent)

14. Birgit Jordan (3 patents)

15. Thomas Jarchau (1 patent)

4 patents: Sort by Forward Citations

1. 8222238 - Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species (2012-07-17),

2. 6849438 - Isolated and purified human soluble guanylyl cyclase α1/β1 (hsgcα1/β1) (2005-02-01),

3. 6844343 - N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent (2005-01-18),

4. 6649421 - Antibodies against phoshorylated VASP (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use (2003-11-18),

Vasopharm Biotech GmbH is a leading biotech company focused on developing therapeutics for the treatment of neurological diseases. Their innovative approach involves targeting the vasopressin system to improve outcomes for patients suffering from conditions such as stroke, traumatic brain injury, and other neurological disorders.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

4 Patents

#13 in Wurzburg

#7,022 in Germany

Wurzburg, Germany

Vasopharm Biotech Gmbh